- Home
- EHTH vs TNGX Comparison
EHTH vs TNGX Comparison
Compare EHTH & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- TNGX
- Stock Information
- Founded
- EHTH 1997
- TNGX 2014
- Country
- EHTH United States
- TNGX United States
- Employees
- EHTH N/A
- TNGX N/A
- Industry
- EHTH Specialty Insurers
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- TNGX Health Care
- Exchange
- EHTH Nasdaq
- TNGX Nasdaq
- Market Cap
- EHTH 292.7M
- TNGX 317.4M
- IPO Year
- EHTH 2006
- TNGX N/A
- Fundamental
- Price
- EHTH $6.68
- TNGX $1.37
- Analyst Decision
- EHTH Buy
- TNGX Strong Buy
- Analyst Count
- EHTH 4
- TNGX 7
- Target Price
- EHTH $6.38
- TNGX $12.33
- AVG Volume (30 Days)
- EHTH 235.7K
- TNGX 789.1K
- Earning Date
- EHTH 05-06-2025
- TNGX 05-07-2025
- Dividend Yield
- EHTH N/A
- TNGX N/A
- EPS Growth
- EHTH N/A
- TNGX N/A
- EPS
- EHTH N/A
- TNGX N/A
- Revenue
- EHTH $532,409,999.00
- TNGX $42,069,000.00
- Revenue This Year
- EHTH $1.50
- TNGX N/A
- Revenue Next Year
- EHTH $8.74
- TNGX N/A
- P/E Ratio
- EHTH N/A
- TNGX N/A
- Revenue Growth
- EHTH 17.56
- TNGX 15.17
- 52 Week Low
- EHTH $3.58
- TNGX $1.33
- 52 Week High
- EHTH $11.36
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- EHTH 30.93
- TNGX 26.22
- Support Level
- EHTH $7.13
- TNGX $1.48
- Resistance Level
- EHTH $7.13
- TNGX $1.66
- Average True Range (ATR)
- EHTH 0.41
- TNGX 0.16
- MACD
- EHTH -0.05
- TNGX -0.01
- Stochastic Oscillator
- EHTH 10.20
- TNGX 5.63
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.